Table 4.
Multivariate Analysis of Risk Factors Related to the Mortality of COVID-19 Patients
| B | SE | Wald | P | OR | 95% CI | |
|---|---|---|---|---|---|---|
| Age | 0.050 | 0.039 | 1.703 | 0.192 | 1.052 | 0.975–1.134 |
| Cancer | 3.806 | 1.574 | 5.851 | 0.016 | 44.973 | 2.059–982.524 |
| WBC | 0.919 | 1.322 | 0.484 | 0.487 | 0.399 | 0.030–5.319 |
| Lymphocytes | 3.388 | 2.375 | 2.035 | 0.154 | 0.034 | 0.000–3.550 |
| Neutrophils | 1.055 | 1.358 | 0.604 | 0.437 | 2.872 | 0.201–41.096 |
| CRP | 0.007 | 0.007 | 1.113 | 0.292 | 1.007 | 0.994–1.021 |
| LDL-c/HDL-c ratio | 0.323 | 0.307 | 1.111 | 0.292 | 0.724 | 0.397–1.321 |
| TG/HDL-c ratio | 0.548 | 0.258 | 4.522 | 0.033 | 1.730 | 1.044–2.866 |
Notes: P values indicate differences between the survivor and non-survivor COVID-19 patients. P < 0.05 was considered statistically significant (marked in bold).
Abbreviations: COVID-19, Coronavirus disease 19; SE, standard error; OR, odds ratio; CI, confidence interval; WBC, White blood cells; CRP, C-reactive proteins; LDL-c/HDL-c ratio, low-density lipoprotein cholesterol-to-high-density lipoprotein cholesterol ratio; TG/HDL-c ratio, triglyceride-to-high-density lipoprotein cholesterol ratio.